Activation of microglial cells in response to ischaemic injury, inflammatory and/or immune stimuli is associated with the marked induction of Toll-like receptor 2 (TLR2). At present, little is known about the spatial and temporal sequence of events, micro-regional specificities and the potential long term role of the TLR2 response to brain injuries. To investigate microglial activation/TLR2 response in real time, we generated a transgenic mouse model bearing the dual reporter system luciferase/green fluorescent protein under transcriptional control of a murine TLR2 promoter. In this model, transcriptional activation of TLR2 was visualized in the brains of live animals using biophotonic/bioluminescence molecular imaging and a high resolution/sensitivity charged coupled device camera. It was found that TLR2 induction/microglial activation has a marked chronic component after ischaemic injury and may last several months after the initial attack. The pro-inflammatory response was not restricted to the site of ischaemic injury but was also evident in the olfactory bulb. A significant TLR2 response was first seen in the olfactory bulb 6 h after stroke and several hours before the increase in photon emission over the site of infarction. This sequence of events was further confirmed by immunohistochemistry. A similar early TLR2 response from olfactory bulb microglia was observed in the brain's immune response to pathogens. We therefore propose that, owing to their unique situation, receiving and translating numerous inputs from the brain as well as from the environment, olfactory bulb microglia may serve as sensors and/or modulators of brain inflammation.
Introduction
Microglial cells are the main effectors of the innate immune response following CNS injuries, including ischaemia. Under physiological conditions, they exist in the ramified or 'resting' state, while in response to pathogens invasion and/or brain injury, microglial cells are activated, change the morphology into macrophage-like cells and eventually start to proliferate (Raivich et al., 1999; Hanisch and Kettenmann, 2007) . Recent evidence suggests that depending on the type of stimulus, the activation of resident microglial cells may be associated with detrimental and/or beneficial effects on adjacent neurons (Nguyen et al., 2002; Wyss-Coray and Mucke, 2002; Nedergaard and Dirnagl, 2005; Lalancette-Hebert et al., 2007; Lai and Todd, 2008) .
There is growing evidence that post-ischaemic inflammation and activation of resident glial cells plays an important role in the evolution of ischaemic brain injury (Dirnagl et al., 1999; Stoll and Jander, 1999; Moskowitz and Lo, 2003) . Notably, activation of microglial cells in response to inflammatory and/or immune stimuli is associated with the significant induction of several Toll-like receptors (TLRs) (Olson and Miller, 2004; Lehnardt et al., 2007; Trinchieri and Sher, 2007; Ziegler et al., 2007) . While it has been widely established that TLRs are the key mediators in the response to invading pathogens and the recognition of pathogen-associated molecular patterns (PAMPs) (Schwandner et al., 1999; Underhill et al., 1999; Yoshimura et al., 1999) , recent evidence suggests that TLRs, especially Toll-like receptor 2 (TLR2) may have a role in the development of brain damage caused by cerebral ischaemia (Lehnardt et al., 2007; Tang et al., 2007; Ziegler et al., 2007) . Normally, in the mouse brain, TLR2 expression is very low or undetectable but is strongly induced in microglial cells in response to infection or brain injury. At present, little is known about the spatial and temporal dynamics, micro-regional specificities and the potential long term role of the TLR2 response to brain injuries.
To investigate the TLR2 response/microglial activation in vivo, we generated a transgenic mouse model bearing the dual reporter system luciferase and green fluorescent protein under the transcriptional control of a murine TLR2 promoter. In this mouse model, transcriptional activation of TLR2 was visualized in the brains of live animals using biophotonic/bioluminescence imaging and high resolution charged coupled device (CCD) camera. We report that TLR2 induction/microglial activation after ischaemic injury may last several months after the initial attack. Moreover, the TLR2 response was not restricted to the site of ischaemic injury being also evident in the olfactory bulb (OB). A significant TLR2 response was seen first in OB (6 h after stroke), several hours before the increase in photon emission over the site of infarction occurred. Similar dynamic of the TLR2 response in OB microglia was observed in the brain immune response to pathogens, suggesting that OB microglial cells may serve as sensors and/or modulators of brain inflammation.
Materials and Methods

DNA constructs
A fragment of 1548 base pair (bp) from the murine TLR2 promoter was amplified by polymerase chain reaction (PCR) from the 158H14 clone isolated from the RPCI-24 mouse (C57Bl/6J male) bacterial artificial chromosome (BAC) library under standard conditions by using the Expand HiFi PCR System (Roche, Mississauga, Ontario, Canada) with oligonucleotides corresponding to pGL3-1486 and pGL3 antisense (Musikacharoen et al., 2001 ) but with different restriction sites (Primer 309: 5 0 -gggactagtggttgagaccccatggtggtt-3 0 and
Primer 310: 5 0 -gggctgcagtctgggcaccagcctaggaag-3 0 ). A larger DNA fragment (2812 bp) from the murine TLR2 promoter was similarly amplified using primer 297: 5 0 -gggactagttcgatctgtgtctcagtt-3 0 and primer 310. The PCR-amplified fragments were inserted into the pCR2.1 vector (TA cloning kit; Invitrogen, Burlington, Ontario, Canada) and completely sequenced to verify their integrity. The Spe1/Pst1 promoter fragments of 1548 (TLR2/S) or 2812 bp (TLR2/L) were inserted into the Internal Ribosome Entry Site (pIRES) vector (BD Biosciences, Mississauga, Ontario, Canada). The Nhe1/Sal1 1.7-kb fragment corresponding to the luciferase reporter gene (luc2) from pGL4 (Promega, Madison, WI, USA) and the Sal1/Not1 0.7-kb fragment corresponding to the Aequorea coerulescens Green Fluorescent Protein (AcGFP) reporter gene from pAcGFP1 (BD Biosciences, Mississauga, Ontario, Canada) were both inserted into the pIRES recombinant vector. The integrity of the final construct was verified by sequencing.
Generation of transgenic mice and genotyping
The TLR2 promoter-luciferase-AcGFP transgenes were isolated as a $5.2-kb Spe1/Cla1 (TLR2/S) or a $6.5-kb Spe1/Cla1 (TLR2/L) fragment of pIRES-TLR2-LUC2-AcGFP-p(A) and microinjected into the male pronucleus of fertilized C57BL/6 oocytes. Transgenic mice were generated in the Transgenic and Knockout Facility of the Research Centre of the Centre Hospitalier de l'Université Laval (CHUL). Transgenic animals were identified by PCR detection of luciferase and/or Southern blot analyses. The genotyping was performed as previously described (Cordeau et al., 2008) .
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA from various tissues was isolated using the Trizol Reagent (Invitrogen). The DNase1-treated RNA was reverse transcribed into cDNA using random hexamer oligonucleotides and the SuperScript II Reverse Transcriptase kit (Invitrogen). Subsequent PCR amplification was performed using the oligonucleotides specific to luciferase. The mouse b-actin was PCR-amplified using the oligonucleotides K9: 5 0 -gcggactgttactgagctgcgt-3 0 and K10: 5 0 -gaagcaatgctgtcaccttccc.
Surgical procedures-experimental ischaemia
Unilateral transient focal cerebral ischaemia was induced as previously described (Belayev et al., 1999; Beaulieu et al., 2002; Lalancette-Hebert et al., 2007) by intraluminal filament occlusion of the left middle cerebral artery (MCA) during 1 h followed by a reperfusion period.
Surgical procedures-stereotaxic brain injection
The mice were anesthetized with 2% isoflurane in 100% oxygen at a flow rate of 2 l/min and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, USA). Transgenic and wild-type (WT) mice received intracerebral injection of lipopolysaccharide (LPS) (2.5 mg) from Escherichia coli, serotype O55:B5 or sterile saline solution (0.9%) into the right parietal region of cerebral cortex. The coordinates for the stereotaxic injection were the following: 2.0 mm posterior, 2.0 mm lateral (right) and -1.5 mm dorsoventral to the bregma (Franklin and Paxinos, 1997) . The injections were performed using a 33-gauge stainless steel cannula (Plastics One, Roanoke, VA, USA) was connected to a 25-ml Hamilton syringe. A volume of 1 ml was infused over 2 min using a microinjection pump (model A-99; Razel Scientific Instruments, St. Albans, VT, USA).
Intranasal administration of LPS
After anaesthesia, the transgenic mice and control mice (n = 4) received intra-nasally (left nostril), 5 ml of LPS (5 mg dissolved in 0.9% sterile saline solution) or 5 ml of sterile 0.9% saline solution, respectively. The animals were then longitudinally imaged using in vivo bioluminescence.
In vivo bioluminescence imaging
As previously described (Maysinger et al., 2007; Cordeau et al., 2008) , the images were gathered using IVIS Õ 200 Imaging System (CaliperLSXenogen, Alameda, CA, USA). Twenty-five minutes prior to imaging session, the mice received intraperitoneal (i.p.) injection of the luciferase substrate D-luciferine (150 mg/kg-for mice between 20 and 25 g, 150-187.5 ml of a solution of 20 mg/ml of D-luciferine dissolved in 0.9% saline was injected) (CaliperLS-Xenogen). The 3D reconstruction of bioluminescent sources in the brain was accomplished by using diffuse luminescent imaging tomography (DLIT) algorithms (Living Image 3D Analysis Software, CaliperLS-Xenogen).
Tissue collection
The animals were anaesthetized by an i.p. injection of chloral hydrate (150 mg/kg, 300-350 ml of solution, concentration 10 mg/ml) and transcardially perfused with 30 ml of 0.9% saline, followed by 4% paraformaldehyde (PFA) at pH 7.4 dissolved in phosphate buffered saline (PBS). Tissue sample were then postfixed overnight in 4% PFA and equilibrated in PBS/30% sucrose for 48 h. Brains were embedded into Tissue-Tek Õ (O.C.T. compound, Sakura, USA) and frozen at -20 C, cut into coronal section with a Cryostat (35-mm thick) and stored at -20 C.
In situ hybridization and immunohistochemistry
Immunohistochemistry was performed on the brain section of mice subjected to MCAO or LPS injections and appropriate controls according to the previously described procedures S-labelled riboprobes. Protocols for probe synthesis and in situ hybridization were previously described by Lalancette-Hebert et al. (2007) .
Immunofluorescence
As previously described , the sections were then incubated overnight at room temperature using primary antibodies, 1:750 mouse monoclonal anti-Map2 (Millipore), 1:500 rabbit polyclonal anti-GFAP (Millipore), 1:750 Rabbit polyclonal antiIba1 (Wako), 1:250 mouse anti-TLR2 (eBioscience, Burlington, Ontario, Canada), 1:1000 anti-doublecortin (DCX) (Abcam, Cambridge, MA, USA) and 1:500 mouse monoclonal anti-green fluorescent protein (GFP) (Invitrogen), 1:1500 anti-CD68 (Serotec, Raleigh, NC, USA), 1:1000 anti-Mac2 (ATCC, Manassas, VA, USA), 1:500 anti-cleaved caspase 3 (New England Biolabs, Pickering, Ontario, Canada). After wash in PBS, the sections were incubated in corresponding fluorescent goat secondary antiserum (Invitrogen).
Statistical analysis
Multiple comparisons non-parametric test (Kruskal-Wallis test) followed by a Dunn's post-test were used to compare total photon emission over the time within selected pairs of groups (Figs 2 and 3) . Unpaired t-test was used to compare the total photon emission in the two different ROI in the same mouse at a same time point when the variances were equivalent between the two groups. If the variances were not equivalent, an unpaired t-test followed by a Welch's test was performed (Fig. 3) .
Results
Generation of transgenic mice for visualization of microglial activation/ innate immune response in the brain To visualize microglial activation from the brain of live animals, we generated transgenic mice bearing the dual, bicistronic reporter system firefly-luciferase (LUC) and green fluorescent protein (GFP) under transcriptional control of the murine TLR2 gene promoter. The feasibility of this approach was demonstrated in our previous studies (Maysinger et al., 2007; Cordeau et al., 2008) . The advantage of the dual reporter system emerged from the fact that fluorescence signals can be used to achieve microscopic resolution while bioluminescence, owing to favourable emission spectra of luciferase (above 620 nm) is optimized for live imaging. Two different DNA constructs were microinjected. The first DNA construct called TLR2-275S included 1.5 kb 5 0 upstream DNA sequence of the mouse TLR2 gene promoter that was cloned into the bicistronic construct containing promoter-less luciferase PGL4 (1.7 kb) and AcGFP (0.7 kb) reporters (Fig. 1A) . These two genes were located on either side of the IRES followed by SV40 polyadenylation signal. The second DNA construct called TLR2-374L with longer, 2.8 kb 5 0 upstream DNA sequence was cloned into the same bicistronic LUC/GFP vector (Fig. 1A) . The mouse TLR2 gene promoter has been characterized by Musikacharoen and colleagues (2001) , and the 1.5 and 2.8 kb upstream regions of the TLR2 were found to contain elements for LPS-and tumour necrosis factor (TNF)-mediated promoter activation. Eleven different founders were obtained for the two DNA constructs. Following initial screening, we focused on two lines: one TLR2-275S with the 1.5 kb 'shorter' promoter, and the other, TLR2-374L line, generated with 2.8 kb 'longer' promoter. RT-PCR analysis was carried out to study induction and expression of luciferase mRNA. Systemic LPS administration is a well-established model associated with a strong induction of TLR2 expression (mRNA and protein level) in the central nervous system and potentially in other tissues (Laflamme et al., 2001) . Because TLR2 is normally not induced/expressed in physiological conditions, we used this approach to test functional responsiveness of our transgenic mouse model. As revealed in the Fig. 1B and C, systemic injection of LPS, in line TLR2-275S mice, was associated with a strong induction of luciferase mRNA in the CNS (brain, cerebellum and spinal cord) and in the thymus. The double immunofluorescence analysis revealed that in the brain tissue the expression of TLR2 driven reporter GFP co-localized with the endogenous TLR2 (Fig. 1B) . The same pattern of expression was observed for the line TLR2-374L, with an additional luciferase mRNA induction in skeletal muscle tissue (Fig. 1C ). To confirm that our models are valid in the context of in vivo bioluminescence imaging, we injected LPS (15 mg/kg, i.p.) or 0.9% saline (i.p.) in transgenic mice and then analysed the induction of TLR2 driven luciferase reporter in live animals using a high resolution CCD camera. As expected, the saline injection induced only a weak bioluminescent signal originated from the inguinal lymph nodes surrounding the injection site ( Fig. 1D ). Contrary to a weak bioluminescence signal provoked by saline injection, the injection of LPS was associated with a robust activation of the reporter gene and the apparition of a bioluminescent signal in brain, thymus and inguinal lymph nodes. The signals were first observed as early as 6 h and peaked at 24 h following LPS injection (Fig. 1E ).
In agreement with previous findings (Nguyen et al., 2002) , a systemic injection of LPS was associated with a strong wave of TLR2 induction in the brain (Fig. 1E) . Here, it is important to note that TLR2 promoter activation/bioluminescent signal induction was markedly higher in transgenic line TLR2-275S when compared with values obtained from in vivo imaging evaluation of the line TLR2-374L. In keeping with the previous reports (Musikacharoen et al., 2001) , this finding suggests that 
Ischaemic brain injury induces chronic two-site TLR2 response
According to recent evidence TLRs, especially TLR2, may be implicated in the ischaemic brain damage caused by stroke (Lehnardt et al., 2007; Tang et al., 2007; Ziegler et al., 2007) . To investigate spatial and temporal dynamics of TLR2 induction/microglia activation after ischaemic brain injury, we longitudinally imaged bioluminescent signals from the brain of TLR2-275S mice. The signals were analysed over a 3-month period following transient MCAO ( Fig. 2A-I ). Using this novel in vivo imaging approach, we observed two unexpected primary findings, which were consistent in all experimental groups. First, the inflammatory response after ischaemia had a marked chronic component. As shown in Fig. 2A-I , the photon emission and TLR2 signals/microglial activation were significantly elevated, when compared with control baseline levels, during a 3-months time interval after initial stroke. The quantitative analysis of photon emissions revealed a biphasic response. During the acute phase of the inflammatory response after ischaemia, the levels of TLR2 induction signals peaked 48 h after stroke (1.92 Â 10 5 AE 0.2 Â 10 5 p/s, n = 12) and then slowly declined to a much lower level over an 8-days period. A second TLR2 peak occurred at 28-30 days after MCAO (Fig. 2J ). Statistical analysis revealed that the values at 28-30 days were significantly different from the photon emissions measured at 3 weeks and 1.5 months (1 month: 4.70 Â 10 4 AE 1.56 Â 10 4 p/s, n = 10 versus 3 weeks: 1.69 Â 10 4 AE 0.14 Â 10 4 , n = 10 and 1.5 months: 1.95 Â 10 4 AE 0.3 Â 10 4 p/s, n = 10). With the exception of above described second 28-30 days wave, the total photon emission was constant after 8 days, for as long as 3 months, the last time point analysed. Here, it is important to note that values of total photon emission were significantly raised at all times after ischaemic injury, when compared with control basal level and/or sham operated mice (Fig. 2J ).
Another unexpected finding was a distinct spatial distribution of TLR2 signals after ischaemic injury. In addition to predicted increase in photon emission observed over the area of ischaemic lesion ( Fig. 2C-F) , TLR2 signals increased significantly in the more frontal projection area. This frontal regional activation of TLR2 signals-detectable at low levels in all TLR2-275S mice-was indeed the earliest significant increase in photon emissions after ischaemic injury ( Fig. 2A-C) . As shown in Fig. 2G-I , the TLR2 signals from this micro-region remained significantly activated for at least 3 months. This two-site induction was also revealed using a 3D reconstruction of the imaged bioluminescent signals (Fig. 3) . The neuroanatomical location of TLR2 signals was further confirmed using ex vivo imaging. Interestingly, the OB generated a clear bioluminescent signal even under control conditions (Figs 2A and 3A) ; but this was sharply enhanced 6 h after MCAO (Fig. 4Aand B) . To exclude the possibility that this particular TLR2 response was induced by isofluorane anaesthesia, we repeated the same imaging protocol using i.p. injection of ketamin/xylazine and we obtained the same response over the OB area (data not shown). This suggests that independent of the type of anaesthesia, the subset of OB microglial cells are continually expressing TLR2 and thus may be in a 'primed' and/or alert state. Moreover, statistical analysis of the total photon emission revealed an interesting pattern of events in this region-specific TLR2 response to ischaemic injury. As demonstrated in Fig. 4C , a significant induction of TLR2 signals in OB repeatedly preceded a significant increase in TLR2 signals in and around the ischaemic lesion-stroke area. Statistical analysis of the signal intensities emitted from OB and the stroke area revealed that the first significant increase in TLR2 signals, as compared to control levels, occurred in the OB at 6-h post-ischaemia. At this time point no significant increase in TLR2 signal was measured over the stroke area (SA) suggesting that TLR2 induction, following MCAO, occurs first in the OB. The photon emission signals over SA (Fig. 4C) .
The same pattern of induction was observed at the 2-3 weeks time points when a significant increase in TLR2 signal in OB region preceded 1 month photon emission peak over SA area-SA: 2 weeks: OB: 2.31 Â 10 4 AE 0.18 Â 10 4 , SA: 1.8 Â 10 Â 10 4 p/s P = 0.8087 n = 10) (Fig. 4C ).
To further characterize micro-regional differences of the inflammatory response to ischaemia observed during in vivo imaging experiments, we compared activation profiles of microglial cells in OB and in the ischaemic lesion area-stroke area. The microglial cells were analysed at the base-line levels and at different time points following MCAO. We investigated the expression of known activation markers in microglia such as CD68, Mac-2 (Lalancette- Weng and Kriz, 2007) and TLR2, an activation marker used in the analysis of our novel transgenic model. Immunofluorescence analysis of the brain sections of the OB region revealed that in control conditions, a large number of microglial cells in OB were positive for activation markers CD68, TLR2 and Mac-2 (Fig. 5A, G and M) . In contrast, in control conditions the microglial cells in the brain areas that will be affected by MCAO ischaemia model were completely devoid of any immunoreactivity for CD68, TLR2 and Mac-2 (Fig. 5D , J and P). Similar differences in expression profiles were observed at 6-h post-ischaemia. While in OB microglia, we observed an increase in the expression levels of activation markers (Fig. 5B, H and N) , at the same time point we did not observe any marked increase in CD68, TLR2 and Mac-2 Figure 5 Expression of different markers of microglial activation in OB and in the ischaemic lesion-stroke area (SA). Activated microglial cells were detected by fluorescent immunolabelling of (A-F) CD68, (G-L) TLR2 and (M-R) Mac-2 protein in control conditions (base-line levels) (CTL), 6 and 24 h after stroke in TLR2-275S transgenic mice. Activated microglial cells were found in OB in control conditions and they increased in numbers and changed in shape at 6-to 24-h time period after MCAO. In the SA region, activated microglial cells were mostly observed only 24 h after MCAO. Scale bars: 100 mm (panels A-F) and 25 mm (panels G-R).
immunoreactivities at the site of SA (Fig. 5E , K and Q). The immunofluorescence analysis at 24 h after MCAO revealed, however, a marked increase in the expression levels of CD68, TLR2 and Mac-2 immunoreactivities in the SA (Fig. 5F , L and R), reaching the level (after initial delay of $12 h) and the profile of microglia activation in the OB region. These results confirmed (as previously revealed by in vivo imaging) that OB microglia, contrary to microglial cells from other regions of the CNS, even in control conditions may express 'base-line' levels of activation markers and may continually be in the certain state of alert.
TLR2 transgene induction in the brain mimics the endogenous protein
In the mouse brain, TLR2 expression is very low or undetectable but it is strongly induced in microglial cells in response to cerebral ischaemia and/or LPS stimuli ( Supplementary Figs 1 and 2 ). To further validate our transgenic model, we first analysed the expression pattern of endogenous TLR2 protein. Secondly, we verified whether the TLR2 driven GFP transgene follows the induction profile and expression of endogenous protein. The expression of TLR2 protein was analysed at two key sites of TLR2 response: the site of ischaemic lesion and in OB. Consistent with the bioluminescence imaging data, 48-72 h following MCAO, the endogenous TLR2 protein was induced within the area of ischaemic lesion and the vast majority of cells expressing this receptor were activated microglia (Fig. 6A, Supplementary Fig. 1 ). As shown in Fig. 6B , the TLR2 immunoreactivity co-localized with Iba1 staining. Larger magnification photomicrographs revealed that TLR2 was selectively induced in the microglial cells displaying activated morphology (Fig. 6D) . Microglial cells outside the ischaemic lesion (with exception of OB) were completely devoid of TLR2 immunoreactivity ( Supplementary Figs 1 and 3) . In addition to activated microglial cells, a small proportion of TLR2 immunoreactivity was detected in a limited number of neurons. The Map2 and TLR2 immunostaining co-localized only in a small number of neurons found within the centre of ischaemic lesion ( Fig. 6C and E). This distribution of neuronal TLR2 immunostaining is consistent with expression pattern of cleaved caspase-3 positive, stressed or dying neurons Tang et al., 2008) . Additional double-immunofluorescence analysis revealed that a certain number of TLR2 positive neurons were also immunoreactive for cleaved caspase-3, a marker of apoptosis (data not shown). Neurons outside the centre of ischaemic lesion did not express TLR2. Next, we analysed the expression of TLR2 driven GFP-transgene ( Fig. 6F-J) . As shown in Fig. 6G and I, the GFP immunoreactivity co-localized with Iba1 immunostaining (microglial cells with amoeboid morphology) and with limited numbers of Map2 positive neurons situated within the centre of ischaemic lesion ( Fig. 6H and J) showing the same expression pattern as endogenous TLR2 (Fig. 6A-E) , (Supplementary Figs 1 and 3 ). In addition, we did not observe TLR2 induction in the GFAP positive activated astrocytes ( Supplementary Figs 1 and 3) . The second key region of interest was the OB. As shown in Fig. 7A and B, and consistent with our in vivo imaging results, the double immunofluorescence analysis of OB revealed that the primed (alerted) Iba1 positive microglial cells were present in control conditions in relatively large numbers in the glomerular cell layer (note that microglial cells with less activated phenotypes and in smaller numbers were present in other regions of OB, data not shown). The Iba1 immunostaining co-localized with TLR2 driven GFP-transgene immunoreactivity before stroke (controls), as well as 6 h after MCAO (Fig. 7B and C) . However, at 6 h after ischaemic insult, the Iba1/GFP expressing microglia displayed more amoeboid-activated morphology (Fig. 7C) . Although $95% of TLR2-GFP expressing cells were Iba1 positive microglia, a small subset (about 5%) of TLR2-GFP cells were positive for DCX and were situated in the projection areas of the rostral migratory stream (Fig. 7A and D) . This is consistent with recent findings (Rolls et al., 2007) suggesting that TLR2 receptors may be found on adult neuronal progenitor cells, and/or migrating neuroblasts that are normally DCX positive. Importantly, analysis of the endogenous TLR2 protein expression pattern revealed that it is identical to the expression pattern of the TLR2 driven GFP-transgene ( Fig. 7E-G) . Here, it is important to mention that the detected ratio for TLR2 expression was 95% Iba1-5% DCX, and this ratio did not change at later points after stroke (1-1.5 months) (data not shown).
Intracerebral administration and external exposure to pathogens induce marked TLR2 response in olfactory bulb
Recent evidence suggests that the brain inflammatory response and microglial activation may be directly affected and/or modulated by signals arising from injured neurons (Biber et al., 2007; Lai et al., 2007) . Our above-mentioned results suggest that OB microglia are rapidly activated in response to relatively distant neuronal-ischaemic injury. However, what is not known at present is whether OB microglial cells could display a similar pattern of rapid activation in response to pathological stimuli without direct neuronal injury. If that is the case, it would suggest a more general involvement of OB microglial cells in the modulation of CNS inflammation. To address this question we analysed the TLR2 response in the well-established models of LPS induced microglial activation. As expected, our live imaging analysis revealed that intracerebral injection of LPS in TLR2-275S transgenic mice was associated with a strong induction of bioluminescence signal observed over the site of application (Fig. 8A-C) . Importantly, in parallel to TLR2 induction at the LPS topical application site, we also observed a significant increase of bioluminescence in OB region (Fig. 8A-C) . The significant increase in TLR2 bioluminescent signal was detectable as early as 6 h after injection, while a peak of expression was observed in transgenic mice 24 h after LPS injection (Fig. 8A-C) . This was followed by a decline in TLR2 signal expression to control (saline application) levels after 48 h (data not shown). To confirm that transgene induction and expression patterns followed endogenous TLR2 expression, we performed double immunofluorescence analysis accompanied by in situ hybridization analysis (Fig. 8, Supplementary Fig. 2 ). As revealed in Fig. 8D and E, the endogenous TLR2 protein as well as the TLR2 driven GFP transgene co-localized with the microglial marker Iba1. Importantly, this Iba1 positive cell population shares an amoeboid morphology, indicating the activated state of microglia ( Fig. 8D and E) suggesting that TLR2 induction was associated with LPS induced activation. In addition, in situ hybridization analysis in combination with immunohistochemistry after LPS injection revealed TLR2 mRNA transcripts exclusively in Iba1 positive cells, while no co-localization was detected between TLR2 transcripts and GFAP or NeuN immunoreactivities ( Supplementary  Fig. 2 ).
While our data revealed that OB microglial cells are strongly induced and may modulate pro-inflammatory signals arising from the structures in the brain, it is not yet clear whether the same subpopulation of microglial cells can transmit/translate potential danger and other type of signals from the external environment to the brain and therefore modulate 'outside-in' inflammatory response. To test this possibility, we administered intra-nasally a small amount of dissolved LPS and imaged the brain inflammatory response longitudinally. As expected before LPS inhalation, the mice showed a discrete bioluminescence signal over OB projection area (Fig. 9A ). Importantly, 6 h after LPS inhalation, the TLR2 signals started to spread over distant areas of the brain, peaking at 24 h (Fig. 9A-C) . The detailed analysis of the TLR2 signal induction and spatial distribution revealed that a single, small dose of inhaled LPS was able to produce a widespread wave of TLR2 induction/microglial activation across the mouse brain. As suggested by in vivo imaging projections (red colour intensity code) ( Fig. 9B and C) , 24 h after LPS inhalation, the TLR2 wave spread from the OB region (the highest induction was present in the glomerular layer microglia) via the lateral and the third ventricles choroid plexus to adjacent brain tissue areas. The schematic representation of signals is shown in Fig. 9D . The red squares represent the area of highest intensity of microglia/macrophage activation and consequent TLR2 induction which was mostly present in the OB glomerular cell layer and choroid plexus (Fig. 9D) . The double immunofluorescence analysis revealed a co-localization between GFP and Iba1 staining ( Fig. 9E  and F) . However, the morphological analysis of the high power micrographs revealed that microglial cells from the red square areas acquired more activated macrophage like amoeboid shapes, while microglial cells represented by the blue squares, generally situated in more distant tissue regions of the brain, had the morphology of the primed-alerted microglial cells (the processes were not completely retracted). These morphological differences may suggest that propagation of the TLR2 response from the OB was first spreading via ventricles and circumventricular organs, choroids plexus, leptomeninges into the deeper brain tissue.
Discussion
Using bioluminescent/biophotonic imaging and a novel TLR2-275 mouse model the TLR2 response and microglial activation from the injured brains of live animals was visualized. The results presented here provide the first in vivo evidence revealing that TLR2 induction/microglial activation after ischaemic injury is associated with a marked chronic component and may last several months after the initial attack. Further, we detected two major sites of TLR2 response to ischaemic injury; the site of ischaemic lesion and the OB. Interestingly, the initial site of microglial activation was the OB and the increase at site of ischaemic lesion was preceded by a significant increase of TLR2 signal in OB. Moreover, in addition to response to ischaemic brain injury, an early TLR2 response from OB microglia was observed in the brain's immune response to pathogens, suggesting a more general role of OB microglial cells in the regulation of inflammatory processes in the brain.
Microglial cells are the main effectors of the innate immune response in the brain and once activated they start expressing different TLRs (Nguyen et al., 2002; Laflamme et al., 2003) . The vertebrate-related TLRs-identified by homology to the Toll protein, initially discovered in Drosophila melanogaster-are highly conserved proteins and play an important role in the function of innate immune system (Medzhitov et al., 1997; Lemaitre, 2004) . Mammalian TLRs are at least 13 members of a large family of membrane proteins and their functional role is the transduction of signals into the cell by NF-kB pathways via the adaptor molecule MyD88 and a TIR-domain-containing adaptor protein. They can also transduce signals via MAPK, PI3-K or others pathways essential for modulation of biological activities (Takeda and Akira, 2003; Akira, 2006) . After brain pathogen exposition and/or injury, TLR2 is predominately induced in microglial cells (Olson and Miller, 2004; Jack et al., 2005; Lehnardt et al., 2007) . Some recent studies suggest that TLR2 may be detected in other cell types such as endothelial cells, T lymphocytes and stressed neurons and neuronal progenitors (Xu et al., 2005; Lehnardt et al., 2007; Rolls et al., 2007; Tang et al., 2007; Ziegler et al., 2007) . However, analysis of our results (mRNA as well as the protein levels) revealed that in the brain, following LPS injection, TLR2 was exclusively induced in activated microglial cells, while following ischaemic injury, TLR2 was strongly induced in microglial cells and in the limited subset of neurons localized in the core of ischaemic lesion (see Supplementary Figs 1 and 2) . We did not observe TLR2 induction in GFAP stained activated astrocytes. These findings are in concordance with previous reports on TLR2 induction following brain injuries or LPS exposure (Laflamme et al., 2001) . Importantly, the same pattern of TLR2 induction/expression was observed in the reporter mouse where the TLR2 driven GFP-transgene followed the expression pattern of endogenous TLR2 protein (Figs. 5-7), thus suggesting that TLR2-275 is a valid model to study the TLR2 response and inflammation in CNS.
TLRs are the key mediators of immune response against different microbial agent (Beg, 2002; Nguyen et al., 2002; Aravalli et al., 2007) . However, there is a growing line of evidence suggesting that TLRs can be activated by endogenous 'danger signals' released from injured or necrotic cells (Matzinger, 2002; Kielian, 2006) . More particularly, TLR2 and TLR4 can interact with endogenous alarm signals such as heat shock proteins (Hsp60 and 70), extracellular breakdown product of hyaluron lipoproteins, etc., suggesting that TLRs may be involved in the regulation of inflammatory response following brain injuries (Habich et al., 2002; Osterloh and Breloer, 2008; Asea, 2008) . In addition, it has been demonstrated that NF-kB activation by necrotic cells is dependent of TLR2 expression (Li et al., 2001; Beg, 2002) .
At present, the exact role of TLRs, especially the TLR2, in brain injuries is not understood. The results of recent studies employing TLR2 knockout mice suggest a detrimental role of TLR2 in cerebral ischaemia (Lehnardt et al., 2007; Tang et al., 2007; Ziegler et al., 2007) . Tang et al., and Ziegler and colleagues observed a strong induction of TLR2 protein in microglial cells and in the subset of ischaemic neurons at the site of the ischaemic lesion (Lehnardt et al., 2007; Tang et al., 2007; Ziegler et al., 2007) . Their analysis was limited to acute 36-48 h periods after initial ischaemic attack and restricted to the site of infarction. Analysis of TLR2 response using in vivo bioluminescence imaging revealed a much more intriguing sequence of events. The first significant increase in TLR2 signals after MCAO was detected in OB as early as 6 h after stroke, while at 24-72 h the signal spread out and the peak intensity moved over the area of ischaemic lesion (Fig. 2) . Finally, the longitudinal analysis of the TLR2 signals revealed that they were significantly elevated over the period of several months after initial ischaemic attack, suggesting that post-ischaemic inflammatory process may last much longer than initially thought.
Also the TLR2 response to ischaemic injury was biphasic with the TLR2 response arising first in the OB. Namely, the acute (24-48 h) and the chronic (1 month) TLR2-peaks detected over the site of ischaemic lesion were always preceded with a significant increase and/or wave of TLR2 signal in OB (Fig. 4) . Although some previous findings revealed that OB may contain a significant inducible pool of activated microglia during development and olfactory nerve injury (Fiske and Brunjes, 2000; Chang et al., 2003) , to the best of our knowledge, our work represents the first in vivo evidence suggesting that the post-ischaemic inflammatory microglial response may be modulated by a population microglial cells situated in a distant neuroanatomical region such as OB. Moreover, our additional results revealed that the 'modulating' properties of OB microglia may not be related only to the postinjury inflammatory response. Using LPS as a known paradigm of pathogen induced immune stimuli, we observed that OB microglial cells were not only activated in parallel with the microglial cells at the site of LPS application in the brain, but they were also able to translate and/or transduce a TLR2 response/microglial activation signals caused by inhalation of LPS from the external environment into the brain (Fig. 8) .
The question that should be raised here is: what is the role of OB and/or OB microglial cells in the modulation of inflammatory and immune responses and why this particular subset of microglial cells would exert more alerted, activated phenotype? The part of the answer may be in the fact that the OB has, neuroanatomically, a very distinct position being at the inter-phase between external environment and the brain. In all our control groups, using different types of anaesthesia (i.p. versus inhalation), the OB microglia were continually primed and expressed TLR2 which was not the case with the ramified, resting microglial cells from other regions of the brain. Under physiological conditions microglial cells from other brain regions are completely devoid of TLR2 immunoreactivity (see supplementary Fig. 3) . The exposure to various external pathogens and/or molecules (Calderon-Garciduenas et al., 2003) and the continuous presence of the renewal/apoptotsis of rostral migratory stream neuron progenitors (that naturally occurs in the adult OB) may have given OB microglial cells distinct properties, pre-setting them for the permanent alert position (Fiske and Brunjes, 2000) . Moreover, as recently suggested, we cannot exclude the possibility of the 'provincially' adapted subset of microglial cells that may exert different properties and/or lower activation thresholds (Hanisch and Kettenmann, 2007) . Notably, the results of our study suggest that OB microglia may indeed represent functionally distinct population of microglial cells.
In conclusion, using bioluminescent/biophotonic imaging and novel TLR2-275 mouse model, we visualized microglial activation and TLR2 responses from the brains of live animals. Based on our results, we propose that due to a unique neuroanatomical position, receiving and translating the numerous inputs from the brain as well as from environment the OB microglia may actually serve as sensors and/or modulators of pro-inflammatory events in the brain. In keeping with this, hypothesis is the recent findings of Vroon et al. (2007) showing an early microgliosis and inflammation in OB in Parkinson's patients and in the MTPT-induced disease model in mice. Altogether, the results presented here may provide a valuable novel knowledge on the complex spatial and temporal nature of the inflammatory response in the brain.
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